Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bennet

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Journal of Medical Genetics|January 2, 1995
Clinical and biochemical analysis of two families with type I and type II mannosidosisJ K Bennet, P P Dembure, L J Elsas
Cancer Genetics and Cytogenetics|September 1, 1987
Clonal chromosome abnormalities in two liposarcomasF Mertens, B Johansson, N Mandahl, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
Injectable gold for rheumatoid arthritisP Clark, P Tugwell, K Bennet, et al.
The Journal of Urology|December 13, 2002
Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinenceSiamak Daneshmand, David A Ginsberg, James K Bennet, et al.
International Journal of Cancer|June 15, 1987
Lipomas have characteristic structural chromosomal rearrangements of 12q13-q14N Mandahl, S Heim, B Johansson, et al.
Ecology and Evolution|August 9, 2021
Streetlights positively affect the presence of an invasive grass speciesShannon M Murphy, Dhaval K Vyas, Jennifer L Hoffman, et al.
Ebiomedicine|October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
The Journal of Infectious Diseases|November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Journal of Medical Genetics|January 2, 1995
Clinical and biochemical analysis of two families with type I and type II mannosidosisJ K Bennet, P P Dembure, L J Elsas
Cancer Genetics and Cytogenetics|September 1, 1987
Clonal chromosome abnormalities in two liposarcomasF Mertens, B Johansson, N Mandahl, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
Injectable gold for rheumatoid arthritisP Clark, P Tugwell, K Bennet, et al.
The Journal of Urology|December 13, 2002
Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinenceSiamak Daneshmand, David A Ginsberg, James K Bennet, et al.
International Journal of Cancer|June 15, 1987
Lipomas have characteristic structural chromosomal rearrangements of 12q13-q14N Mandahl, S Heim, B Johansson, et al.
Ecology and Evolution|August 9, 2021
Streetlights positively affect the presence of an invasive grass speciesShannon M Murphy, Dhaval K Vyas, Jennifer L Hoffman, et al.
Ebiomedicine|October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
The Journal of Infectious Diseases|November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Pageof 1